BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 25687758)

  • 1. PRL-3 mediates the protein maturation of ULBP2 by regulating the tyrosine phosphorylation of HSP60.
    Leung WH; Vong QP; Lin W; Bouck D; Wendt S; Sullivan E; Li Y; Bari R; Chen T; Leung W
    J Immunol; 2015 Mar; 194(6):2930-41. PubMed ID: 25687758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A conserved WW domain-like motif regulates invariant chain-dependent cell-surface transport of the NKG2D ligand ULBP2.
    Uhlenbrock F; van Andel E; Andresen L; Skov S
    Mol Immunol; 2015 Aug; 66(2):418-27. PubMed ID: 25983110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor suppressive microRNAs miR-34a/c control cancer cell expression of ULBP2, a stress-induced ligand of the natural killer cell receptor NKG2D.
    Heinemann A; Zhao F; Pechlivanis S; Eberle J; Steinle A; Diederichs S; Schadendorf D; Paschen A
    Cancer Res; 2012 Jan; 72(2):460-71. PubMed ID: 22102694
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The human NKG2D ligand ULBP2 can be expressed at the cell surface with or without a GPI anchor and both forms can activate NK cells.
    Fernández-Messina L; Ashiru O; Agüera-González S; Reyburn HT; Valés-Gómez M
    J Cell Sci; 2011 Feb; 124(Pt 3):321-7. PubMed ID: 21224393
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The NKG2D ligand ULBP2 is specifically regulated through an invariant chain-dependent endosomal pathway.
    Uhlenbrock F; Hagemann-Jensen M; Kehlet S; Andresen L; Pastorekova S; Skov S
    J Immunol; 2014 Aug; 193(4):1654-65. PubMed ID: 25024379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The phosphatase of regenerating liver-3 (PRL-3) is important for IL-6-mediated survival of myeloma cells.
    Slørdahl TS; Abdollahi P; Vandsemb EN; Rampa C; Misund K; Baranowska KA; Westhrin M; Waage A; Rø TB; Børset M
    Oncotarget; 2016 May; 7(19):27295-306. PubMed ID: 27036022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interferon-gamma down-regulates NKG2D ligand expression and impairs the NKG2D-mediated cytolysis of MHC class I-deficient melanoma by natural killer cells.
    Schwinn N; Vokhminova D; Sucker A; Textor S; Striegel S; Moll I; Nausch N; Tuettenberg J; Steinle A; Cerwenka A; Schadendorf D; Paschen A
    Int J Cancer; 2009 Apr; 124(7):1594-604. PubMed ID: 19089914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of NKG2D-ligand cell surface expression by intracellular calcium after HDAC-inhibitor treatment.
    Jensen H; Hagemann-Jensen M; Lauridsen F; Skov S
    Mol Immunol; 2013 Mar; 53(3):255-64. PubMed ID: 22964480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phosphatase of regenerating liver-3 promotes migration and invasion by upregulating matrix metalloproteinases-7 in human colorectal cancer cells.
    Lee SK; Han YM; Yun J; Lee CW; Shin DS; Ha YR; Kim J; Koh JS; Hong SH; Han DC; Kwon BM
    Int J Cancer; 2012 Aug; 131(3):E190-203. PubMed ID: 22131018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A selective phosphatase of regenerating liver phosphatase inhibitor suppresses tumor cell anchorage-independent growth by a novel mechanism involving p130Cas cleavage.
    Daouti S; Li WH; Qian H; Huang KS; Holmgren J; Levin W; Reik L; McGady DL; Gillespie P; Perrotta A; Bian H; Reidhaar-Olson JF; Bliss SA; Olivier AR; Sergi JA; Fry D; Danho W; Ritland S; Fotouhi N; Heimbrook D; Niu H
    Cancer Res; 2008 Feb; 68(4):1162-9. PubMed ID: 18281492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human NK cells are alerted to induction of p53 in cancer cells by upregulation of the NKG2D ligands ULBP1 and ULBP2.
    Textor S; Fiegler N; Arnold A; Porgador A; Hofmann TG; Cerwenka A
    Cancer Res; 2011 Sep; 71(18):5998-6009. PubMed ID: 21764762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of IL-32alpha increases natural killer cell-mediated killing through up-regulation of Fas and UL16-binding protein 2 (ULBP2) expression in human chronic myeloid leukemia cells.
    Cheon S; Lee JH; Park S; Bang SI; Lee WJ; Yoon DY; Yoon SS; Kim T; Min H; Cho BJ; Lee HJ; Lee KW; Jeong SH; Park H; Cho D
    J Biol Chem; 2011 Apr; 286(14):12049-55. PubMed ID: 21321117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Corticotropin-releasing factor induces immune escape of cervical cancer cells by downregulation of NKG2D.
    Song H; Park H; Park G; Kim YS; Lee HK; Jin DH; Kang HS; Cho DH; Hur D
    Oncol Rep; 2014 Jul; 32(1):425-30. PubMed ID: 24841552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phosphatase of regenerating liver-3 directly interacts with integrin β1 and regulates its phosphorylation at tyrosine 783.
    Tian W; Qu L; Meng L; Liu C; Wu J; Shou C
    BMC Biochem; 2012 Oct; 13():22. PubMed ID: 23092334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of silencing phosphatase of regenerationg liver-3 expression by microRNA interference in the growth of gastric cancer.
    Cai SR; Wang Z; Chen CQ; Wu WH; He YL; Zhan WH; Zhang CH; Cui J; Wu H
    Chin Med J (Engl); 2008 Dec; 121(24):2534-8. PubMed ID: 19187591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stathmin, a new target of PRL-3 identified by proteomic methods, plays a key role in progression and metastasis of colorectal cancer.
    Zheng P; Liu YX; Chen L; Liu XH; Xiao ZQ; Zhao L; Li GQ; Zhou J; Ding YQ; Li JM
    J Proteome Res; 2010 Oct; 9(10):4897-905. PubMed ID: 20806969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effects of phosphatase of regenerating liver cell-3 gene silence by RNA interference on the expression of matrix metalloproteinases-2,-9 in human colon cancer cells].
    Fan Y; Zhang YL; Zheng S
    Zhonghua Wei Chang Wai Ke Za Zhi; 2008 Sep; 11(5):477-81. PubMed ID: 18803055
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD44 3'-Untranslated Region Functions as a Competing Endogenous RNA to Enhance NK Sensitivity of Liver Cancer Stem Cell by Regulating ULBP2 Expression.
    Weng J; Han X; Liu K; Yang J; Wei S; Zhang Y; Zeng F; Li Y; Shen L; Gao Y
    Int J Biol Sci; 2019; 15(8):1664-1675. PubMed ID: 31360109
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High expression of PRL-3 can promote growth of gastric cancer and exhibits a poor prognostic impact on patients.
    Wang Z; Cai SR; He YL; Zhan WH; Chen CQ; Cui J; Wu WH; Wu H; Song W; Zhang CH; Peng JJ; Huang XH
    Ann Surg Oncol; 2009 Jan; 16(1):208-19. PubMed ID: 19009246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PCBP1 suppresses the translation of metastasis-associated PRL-3 phosphatase.
    Wang H; Vardy LA; Tan CP; Loo JM; Guo K; Li J; Lim SG; Zhou J; Chng WJ; Ng SB; Li HX; Zeng Q
    Cancer Cell; 2010 Jul; 18(1):52-62. PubMed ID: 20609352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.